ASTAX is a private company that uses proprietary technology and licensing to produce natural Astaxanthin. ACN Capital Group acquired the assets of a former leading firm, with more than 25 years dedicated to the research and development of technologies involved with biotechnological processes in the cultivation of microalgae Haematococcus pluvialis. Our Plant is located in the Atacama Desert, in the oasis of Pica, and with 18 hectares property that has 30 productive pools, the plant of ASTAX will deliver in its first stage approximately 40 to 50 kilos of biomass of Haematococcus pluvialis; with concentrations that can reach up to 10%, incorporating the product all the nutritional value of the microalga. Furthermore, our aim is to become a Global leader in the Astaxanthin Global Market and derivatives.